病毒感染SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial.
期刊：The Lancet. Microbe发表年份：2024作者：Brittany L Ober Shepherd; Paul T Scott; Jack N Hutter; Christine Lee; Melanie D McCauley; Ivelese Guzman; Christopher Bryant; Sarah McGuire; Jessie Kennedy; Wei-Hung Chen; Agnes Hajduczki; Thembi Mdluli; Anais Valencia-Ruiz; Mihret F Amare; Gary R Ma